Medicine Information

Vioxx and Bextra Lawsuits Could Tie Up Courts for Years


In September, 2004, pharmaceutical giant Merck voluntarily withdrew its painkilling medication Vioxx from the market. Studies show that Vioxx increases the risk of heart attack and stroke among patients who have used the drug for longer than 18 months. Vioxx, a drug from a family of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, is one of only a few drugs specifically designed to minimize inflammation while avoiding the stomach disorders long associated with other anti-inflammatory medications. Since its introduction in 1999, Vioxx has been a huge success, and sales of the drug worldwide topped $2.5 billion in 2003. That is certainly a great deal of money, but it pales when compared to the amount that Merck stands to lose through product liability lawsuits, which will soon come to court. As of this writing, several thousand lawsuits have been filed nationally, but attorneys estimate that the total number of lawsuits filed could reach a staggering 100,000.

One hundred thousand lawsuits is certainly a formidable number, but that figure could represent only half of the number of lawsuits related to COX-2 inhibitors. Earlier this year, Pfizer voluntarily withdrew its similar medication Bextra from the market, as studies linked the use of Bextra to increased heart attack risk and to a rare skin disorder known as Stevens-Johnson Syndrome. Bextra, another drug in the family of COX-2 inhibitors, works very similarly to Vioxx, and many patients who formerly took Vioxx switched to Bextra after the former was removed from the market last fall. Given that sales of Bextra rose to near Vioxx levels before it was removed from the market, it seems likely that the number of lawsuits filed by patients who claim to have been harmed by their use of Bextra could eventually equal the number of Vioxx lawsuits.

Unless the courts consolidate them into just a few class-action suits, the 200,000 potential lawsuits stemming from problems with Bextra and Vioxx could cripple our courts for the next decade. Patients who believe that they may have been harmed through the use of either Bextra or Vioxx would be well advised to contact an attorney who specializes in pharmaceutical lawsuits as soon as possible. The wait for a resolution in court, particularly for Vioxx lawsuits, could be a very long one. Those who file quickly may get the fastest results.

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Forbes

Five Winners -- And One Loser -- From Medicine's Big Meeting About Blood
Forbes
Matthew Herper , Forbes Staff I cover science and medicine, and believe this is biology's century. Johnny Wolf. Kite Founder Arie Belldegrun and BlueBird CEO Nick Leschly talk gene therapy at the Forbes Healthcare Summit. For the past two days, doctors ...



STAT

Your smartphone as medicine: Digital therapy is here to stay
STAT
The FDA recently approved 1 the first prescription digital therapy, Pear's Reset app 2 and program, which is focused on substance abuse. Others 3 are likely to follow. That means your next trip to the doctor could include a prescription for a mobile ...



DesMoinesRegister.com

Tips for administering medicine to children
DesMoinesRegister.com
As infants and young children grow and gain weight rapidly in early life, a medicine's dose often increases quickly. The dose of a medicine for an infant or child may be greater just several months later, as more weight is gained. Administering the ...



Community Advocate

Metrowest practice offers Functional Medicine
Community Advocate
Hopkinton – If you're sick of feeling unwell and you're looking for a practice that won't just push more pills, you might consider looking into the 4 Better Health Functional Medicine practice in Hopkinton. The practice is owned by Dr. Patti Zub and ...



Cystic Fibrosis News Today

Ontario Researcher Awarded Grant to Develop Precision Medicine Tool for CF
Cystic Fibrosis News Today
Hirota, a respiratory researcher at St. Joseph's and an assistant professor in the department of medicine at McMaster University in Canada, will receive $280,183 over three years under the grant. “Unfortunately, currently approved drugs fail to work in ...



Pharmacists warn of medicine scarcity in Sudan
ReliefWeb
While medicine prices increase, some life-saving medicines have become scarce in Khartoum and other states. Patients and their attendants complained that medicines have become unaffordable. Some medicines prices have exceeded the price issued that the ...

and more »


RowAnalytics' Giro Initiative Brings Precision Medicine Perspective to Neurodegenerative Disorders
GenomeWeb
NEW YORK (GenomeWeb) –RowAnalytics, the Martinos Center for Biomedical Imaging, and Envision Genomics are partnering on a new initiative called Giro Health, which they describe as an open initiative in precision medicine that seeks to improve diagnosis ...



Salt Lake Tribune

Commentary: The Tribune was wrong. Medicine often involves a risk to the patient.
Salt Lake Tribune
(Courtesy of the Utah Department of Health) A health department initiative called Talk to Your Pharmacist placed stickers on bottles to prompt prescribers to talk to their pharmacist about the risk of using opioids. By Lynn Webster | For The Tribune ...



UAB News

Celebrating 25 years of psychiatric medicine at UAB
UAB News
CPM groundbreaking ceremony, 1989. Photo provided by UAB Archives.On Sept. 27, 1989, the University of Alabama at Birmingham broke ground for a new building. The Center for Psychiatric Medicine, as the edifice on Sixth Avenue South was to be called ...



CBC.ca

Why adding beds might not solve the problem of 'hallway medicine' anytime soon
CBC.ca
Beds announced at the end of October to alleviate overcrowding at some hospitals may be slow to come on stream as hiring staff takes time, but some doctors say the move also doesn't address the underlying cause. Dr. Paul Pageau, President of the ...

and more »

Google News

home | site map | Dr. Thad Thomas
© 2006